期刊文献+

应用氪离子激光建立大鼠脉络膜新生血管模型 被引量:2

An Experimental Study on Model Foundation of Choroidal Neovascularization Induced by Krypton Laser in Rats
下载PDF
导出
摘要 目的:探讨应用氪离子激光建立棕色挪威(brown Norway,BN)大鼠脉络膜新生血管(Choroidal neovascularization,CNV)模型的有效性和安全性,并观察CNV形成后的变化规律。方法:选取雄性BN大鼠25只,从中随机选取1只大鼠(2只眼)为空白对照,不进行激光光凝;其余24只大鼠48只眼作为实验组,行视网膜光凝。氪离子激光光凝后3、7、14、21、28及56d分别随机抽取4只实验组大鼠(8只眼),行视网膜荧光血管造影(Fundusfluoresceinangiography,FFA)、组织病理及透射电镜检查。结果:经FFA和病理组织学检查证实,光凝后第7天光凝斑部位开始出现荧光素渗漏(59%),21d荧光素渗漏达高峰(84%);21d后荧光素渗漏稳定。光凝后7 ̄21dCNV最大中央厚度显著增加,21d后无明显改变。结论:应用氪离子激光建立BN大鼠脉络膜新生血管模型安全有效,成模时间短,持续时间长,成模率高。 Objective: To study the efficacy and safety of the model foundation of choroidal neovascularization (CNV) induced by krypton laser in Brown Norway (BN) rats, and observe the trend of the formation and change of CNV after laser photoeoagulation. Methods: Twenty-five male BN rats were used for this study. Two eyes of one rat without any laser photoeoagnlation was randomly selected as the control group and the other forty-eight eyes of twenty-four rats with laser photocoagulation were as the experimental group. Eight eyes of four rats were randomly selected to receive the examination of ftmdus fluorescein angiography (FFA), histopathology and transmission electron microscopy 3, 7, 14, 21, 28 and 56 days after laser photoeoagulation. Results: After laser photoeoagulation, the leakage appeared in burns on the seventh day (59%), reached the peak on the twenty-first day (84%), and kept stable after twenty-one days proved by FFA and histopathology. The central thickness of CNV significantly increased from the seventh day to the twenty-first day and kept stable after twenty-one days. Conclusion: The experimental model of choroidal neovascularization can be induced by krypton laser in BN rats with a stable, safe, long lasting method and using a short time to receive a high successful rate.
作者 崔靖 颜华
出处 《天津医药》 CAS 北大核心 2007年第1期37-39,F0003,共4页 Tianjin Medical Journal
基金 天津市应用基础研究计划面上项目(项目编号:05YFJMJC03200)
关键词 激光 脉络膜新生血管化 大鼠 模型 动物 laser krypton choroidal neovascularization rats models, animal
  • 相关文献

参考文献7

  • 1Murata T, He S, Hangai M, et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization[J]. Invest Ophthalmol Vis Sci, 2000,41(8):2309-2317.
  • 2Yanagi Y, Tamaki Y, Inoue Y, et al. Subconjunctival doxifluridine administration suppresses rat choroidal neovascularization through activated thymidine phosphorylase [J]. Invest Ophthalmol Vis Sci,2003,44(2):751-754.
  • 3Takagi H, King GL, Robinson GS, et al. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericyos and endothelial cells[J]. Invest Ophthalmol Vis Sci, 1996, 37:2165-2176.
  • 4易玉珍.视网膜下新生血管.见:孙为荣主编.眼科病理学[M].北京:人民卫生出版社,1995:322—323.
  • 5Itagaki T, Ohkuma H, Katoh N, et al. Studies on experimental subretinal neovascularization. 1. Development of experimental subretinal neovascularization [J]. Acta Soc Ophthalmol Jpn, 1985,85 (4):600-610.
  • 6王康,王康孙,王玲,陈荣家,石海云.应用半导体激光诱导鼠脉络膜新生血管模型[J].中华眼科杂志,2002,38(12):750-752. 被引量:12
  • 7Yanagi Y, Tamaki Y, Obata R, et al. Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat[J]. Invest Ophthalmol Vis Sci, 2002,43(11):3495-3499.

二级参考文献1

  • 1Xianjin Yi,Nahoko Ogata,Masayuki Komada,Chikako Yamamoto,Kanji Takahashi,Koichiro Omori,Masanobu Uyama. Vascular endothelial growth factor expression in choroidal neovascularization in rats[J] 1997,Graefe’s Archive for Clinical and Experimental Ophthalmology(5):313~319

共引文献11

同被引文献19

  • 1史雪辉,何守志,赵世红.色素上皮衍生因子在大鼠脉络膜新生血管中的表达及意义[J].中华眼科杂志,2004,40(6):404-408. 被引量:15
  • 2张旭乡,贺忠江,阎一鸣,林锦镛,徐深,高建民,许瀛海,颜华.正常羊眼小梁切除联合滤道成形术的研究[J].中华眼科杂志,2007,43(2):129-133. 被引量:5
  • 3于燕萍,崔靖,王颖,颜华.大鼠PEDF基因的克隆及腺病毒表达载体的构建[J].眼科研究,2007,25(4):265-268. 被引量:1
  • 4Ambati J, Ambati BK, Yoo SH, et aL Age-related macular degeneration : etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol, 2003, 48 : 257-293.
  • 5Ciulla TA, Harris A, Kagemann L. Transpupillary subfoveal occult choroidal neovasculaxization: effect on ocular perfusion. Invest Ophthalmol Vis Sci, 2001,42 : 3337-3340.
  • 6Macular photocoagulation study group. Subfoveal neovascular lesions in age-related macular degeneration. Guideline for evaluation and treatment in the macular photocoagulation study. Arch ophthalmol, 1991,109 : 1217-1218.
  • 7Bhutto IA, McLeod DS, Hasagawa T, et aL Pigment epitheliumderived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res, 2006, 82: 99-110.
  • 8Becerra SP, Fariss RN, Wu YQ, et al. Pigment epithelium derived factor in the monkey retinal pigment epithelium and inter photoreceptor matrix: apical secretion and distribution. Exp Eye Res, 2004,78:223-234.
  • 9Stcllmach V, Crawford SE, Zhou W, et aL Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenlc agent pigment epithellum-derived factor. Proc Natl Acad Sci USA, 2001,98:2593-2597.
  • 10Sun XD, Wang FH, Zhang X, et al. PEDF modified pigment epithelium inhibited VEGF-induced choroidal neovascularization in vitro. Invest Ophthalmol Vis Sci, 2006,47:5623.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部